High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure
Status:
Completed
Trial end date:
2018-10-18
Target enrollment:
Participant gender:
Summary
The study will be conducted on patients admitted to Department of Hepatology from Jan 2016 to
Jan 2018 at Institute of Liver & Biliary Sciences, New Delhi. Study group will comprise of
patients with acute liver failure (ALF) who have no option for liver transplant (due to any
reason) or have contraindications for liver transplant or have no prospective living donor
and will be assessed for enrollment in the trial.